Skip to main content
. 2016 Jun 1;32(6):612–619. doi: 10.1089/aid.2014.0351

FIG. 1.

FIG. 1.

(A) Screening of different commercially available monoclonal HIV p24 antibodies with HIV 1 group O strains on ENIA platform. (B) Comparision of monoclonal HIV p24antibodies, ANT-152 with C65690M, on ENIA platform. ENIA, europium nanoparticle immunoassay. Color images available online at www.liebertpub.com/aid